Mike B.
Global Vice President Sensors and Fluid Management Technologies @Fresenius Medical Care
Signup · Get unlimited contacts
WORK HISTORY
Global Vice President Sensors and Fluid Management Technologies @Fresenius Medical Care
Global Head of Sensors and Fluid Management Technologies, Full PL Responsibility, Upstream market readiness and strategy, Downstream Sales, and Integration of Sensors into existing platforms. Strategic Innovation Road Mapping, Precision Medicine Brand Development.
EDUCATION
University of Redlands
Master of Arts (M.A.), International Economics
Weber State University
Bachelor of Science (B.S.), Science/ Technology
USC Marshall School of Business
MBA, business
ABOUT MIKE B.
MedTech Executive | Innovation & Strategy | Precision Health | Startup Growth & Acquisition | Enterprise CommercializationI’m a senior executive in the medical technology space with a passion for scaling transformative healthcare innovations—from startup incubation to global commercialization. With a career spanning both corporate and entrepreneurial environments, I bring a unique ability to navigate between early-stage momentum and enterprise-scale execution.I currently lead global commercial and OEM initiatives for sensor-enabled platforms, including integrating Crit-Line and advanced biosensor technologies into leading dialysis systems up to commercial launch. My background includes spearheading multimillion-dollar product launches, building market access strategies, and aligning cross-functional teams around bold, outcomes-driven goals. Startup Leadership & Strategic Transactions:•Successfully led a MedTech startup from early development through exit, culminating in a strategic acquisition.•Deep experience engaging boards, capital partners, and strategic investors—translating clinical potential into investor confidence and sustainable value.•Comfortable operating at the intersection of science, storytelling, and scale. Commercial Strategy & Execution:•Built and led enterprise sales teams focused on health systems, payers, and IDNs across global markets.•Developed HEHO (Health Economics & Health Outcomes) framework to bridge clinical value and reimbursement.•Created digital-first hybrid go-to-market models with embedded value-based messaging and omnichannel engagement. Innovation Highlights:•ITAS – Intelligent Therapy Anemia System: Co-developed a physiologic digital twin for ESA dosing, improving drug efficiency by 25% and increasing time-in-range >40%.•Adaptive UF: Designed a real-time, closed-loop ultrafiltration algorithm that received FDA Breakthrough designation and demonstrated strong in silico + clinical outcomes.•Crit-Line Technology integration into global dialysis platforms•BCM2 Technology with Cloud applications.(body composition monitoring) Leadership Style:I bring a mix of strategic vision and hands-on execution, with the ability to work across R&D, regulatory, policy, and commercial teams. Whether working with large global teams or high-velocity startups, I focus on building technologies that meaningfully improve patient care—and business models that scale them sustainably.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.